Abstract
Summary
Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism.
LPI (LP Information)' newest research report, the “Aripiprazole Drug Industry Forecast” looks at past sales and reviews total world Aripiprazole Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Aripiprazole Drug sales for 2023 through 2029. With Aripiprazole Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aripiprazole Drug industry.
This Insight Report provides a comprehensive analysis of the global Aripiprazole Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aripiprazole Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Aripiprazole Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aripiprazole Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aripiprazole Drug.
The global Aripiprazole Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Aripiprazole Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Aripiprazole Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Aripiprazole Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Aripiprazole Drug players cover Otsuka Pharmaceutical, Teva, APOTEX, Barr Laboratories, Sun Pharmaceutical, Alembic Pharmaceuticals, Orchid Pharma, Amneal and Aurobindo Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Aripiprazole Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Orally Disintegrating Tablets
Oral Solution
Injection
Segmentation by application
Adult Patients
Pediatric Patients
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Otsuka Pharmaceutical
Teva
APOTEX
Barr Laboratories
Sun Pharmaceutical
Alembic Pharmaceuticals
Orchid Pharma
Amneal
Aurobindo Pharma
Lannett
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aripiprazole Drug market?
What factors are driving Aripiprazole Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aripiprazole Drug market opportunities vary by end market size?
How does Aripiprazole Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Aripiprazole Drug Industry Forecast” looks at past sales and reviews total world Aripiprazole Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Aripiprazole Drug sales for 2023 through 2029. With Aripiprazole Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aripiprazole Drug industry.
This Insight Report provides a comprehensive analysis of the global Aripiprazole Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aripiprazole Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Aripiprazole Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aripiprazole Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aripiprazole Drug.
The global Aripiprazole Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Aripiprazole Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Aripiprazole Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Aripiprazole Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Aripiprazole Drug players cover Otsuka Pharmaceutical, Teva, APOTEX, Barr Laboratories, Sun Pharmaceutical, Alembic Pharmaceuticals, Orchid Pharma, Amneal and Aurobindo Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Aripiprazole Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Orally Disintegrating Tablets
Oral Solution
Injection
Segmentation by application
Adult Patients
Pediatric Patients
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Otsuka Pharmaceutical
Teva
APOTEX
Barr Laboratories
Sun Pharmaceutical
Alembic Pharmaceuticals
Orchid Pharma
Amneal
Aurobindo Pharma
Lannett
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aripiprazole Drug market?
What factors are driving Aripiprazole Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aripiprazole Drug market opportunities vary by end market size?
How does Aripiprazole Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aripiprazole Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Aripiprazole Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Aripiprazole Drug by Country/Region, 2018, 2022 & 2029
2.2 Aripiprazole Drug Segment by Type
2.2.1 Tablets
2.2.2 Orally Disintegrating Tablets
2.2.3 Oral Solution
2.2.4 Injection
2.3 Aripiprazole Drug Sales by Type
2.3.1 Global Aripiprazole Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Aripiprazole Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Aripiprazole Drug Sale Price by Type (2018-2023)
2.4 Aripiprazole Drug Segment by Application
2.4.1 Adult Patients
2.4.2 Pediatric Patients
2.5 Aripiprazole Drug Sales by Application
2.5.1 Global Aripiprazole Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Aripiprazole Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Aripiprazole Drug Sale Price by Application (2018-2023)
3 Global Aripiprazole Drug by Company
3.1 Global Aripiprazole Drug Breakdown Data by Company
3.1.1 Global Aripiprazole Drug Annual Sales by Company (2018-2023)
3.1.2 Global Aripiprazole Drug Sales Market Share by Company (2018-2023)
3.2 Global Aripiprazole Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Aripiprazole Drug Revenue by Company (2018-2023)
3.2.2 Global Aripiprazole Drug Revenue Market Share by Company (2018-2023)
3.3 Global Aripiprazole Drug Sale Price by Company
3.4 Key Manufacturers Aripiprazole Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aripiprazole Drug Product Location Distribution
3.4.2 Players Aripiprazole Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Aripiprazole Drug by Geographic Region
4.1 World Historic Aripiprazole Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Aripiprazole Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Aripiprazole Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Aripiprazole Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Aripiprazole Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Aripiprazole Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Aripiprazole Drug Sales Growth
4.4 APAC Aripiprazole Drug Sales Growth
4.5 Europe Aripiprazole Drug Sales Growth
4.6 Middle East & Africa Aripiprazole Drug Sales Growth
5 Americas
5.1 Americas Aripiprazole Drug Sales by Country
5.1.1 Americas Aripiprazole Drug Sales by Country (2018-2023)
5.1.2 Americas Aripiprazole Drug Revenue by Country (2018-2023)
5.2 Americas Aripiprazole Drug Sales by Type
5.3 Americas Aripiprazole Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aripiprazole Drug Sales by Region
6.1.1 APAC Aripiprazole Drug Sales by Region (2018-2023)
6.1.2 APAC Aripiprazole Drug Revenue by Region (2018-2023)
6.2 APAC Aripiprazole Drug Sales by Type
6.3 APAC Aripiprazole Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aripiprazole Drug by Country
7.1.1 Europe Aripiprazole Drug Sales by Country (2018-2023)
7.1.2 Europe Aripiprazole Drug Revenue by Country (2018-2023)
7.2 Europe Aripiprazole Drug Sales by Type
7.3 Europe Aripiprazole Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aripiprazole Drug by Country
8.1.1 Middle East & Africa Aripiprazole Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Aripiprazole Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Aripiprazole Drug Sales by Type
8.3 Middle East & Africa Aripiprazole Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aripiprazole Drug
10.3 Manufacturing Process Analysis of Aripiprazole Drug
10.4 Industry Chain Structure of Aripiprazole Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aripiprazole Drug Distributors
11.3 Aripiprazole Drug Customer
12 World Forecast Review for Aripiprazole Drug by Geographic Region
12.1 Global Aripiprazole Drug Market Size Forecast by Region
12.1.1 Global Aripiprazole Drug Forecast by Region (2024-2029)
12.1.2 Global Aripiprazole Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aripiprazole Drug Forecast by Type
12.7 Global Aripiprazole Drug Forecast by Application
13 Key Players Analysis
13.1 Otsuka Pharmaceutical
13.1.1 Otsuka Pharmaceutical Company Information
13.1.2 Otsuka Pharmaceutical Aripiprazole Drug Product Portfolios and Specifications
13.1.3 Otsuka Pharmaceutical Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Otsuka Pharmaceutical Main Business Overview
13.1.5 Otsuka Pharmaceutical Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Aripiprazole Drug Product Portfolios and Specifications
13.2.3 Teva Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 APOTEX
13.3.1 APOTEX Company Information
13.3.2 APOTEX Aripiprazole Drug Product Portfolios and Specifications
13.3.3 APOTEX Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 APOTEX Main Business Overview
13.3.5 APOTEX Latest Developments
13.4 Barr Laboratories
13.4.1 Barr Laboratories Company Information
13.4.2 Barr Laboratories Aripiprazole Drug Product Portfolios and Specifications
13.4.3 Barr Laboratories Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Barr Laboratories Main Business Overview
13.4.5 Barr Laboratories Latest Developments
13.5 Sun Pharmaceutical
13.5.1 Sun Pharmaceutical Company Information
13.5.2 Sun Pharmaceutical Aripiprazole Drug Product Portfolios and Specifications
13.5.3 Sun Pharmaceutical Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sun Pharmaceutical Main Business Overview
13.5.5 Sun Pharmaceutical Latest Developments
13.6 Alembic Pharmaceuticals
13.6.1 Alembic Pharmaceuticals Company Information
13.6.2 Alembic Pharmaceuticals Aripiprazole Drug Product Portfolios and Specifications
13.6.3 Alembic Pharmaceuticals Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alembic Pharmaceuticals Main Business Overview
13.6.5 Alembic Pharmaceuticals Latest Developments
13.7 Orchid Pharma
13.7.1 Orchid Pharma Company Information
13.7.2 Orchid Pharma Aripiprazole Drug Product Portfolios and Specifications
13.7.3 Orchid Pharma Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Orchid Pharma Main Business Overview
13.7.5 Orchid Pharma Latest Developments
13.8 Amneal
13.8.1 Amneal Company Information
13.8.2 Amneal Aripiprazole Drug Product Portfolios and Specifications
13.8.3 Amneal Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Amneal Main Business Overview
13.8.5 Amneal Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma Aripiprazole Drug Product Portfolios and Specifications
13.9.3 Aurobindo Pharma Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Lannett
13.10.1 Lannett Company Information
13.10.2 Lannett Aripiprazole Drug Product Portfolios and Specifications
13.10.3 Lannett Aripiprazole Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Lannett Main Business Overview
13.10.5 Lannett Latest Developments
14 Research Findings and Conclusion